Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Author Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.
Journal: Nature medicine
Published: April 25, 2025
Synthetic helical peptide capping strategies.
Journal: Chemical Society reviews
Published: July 05, 2022
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
Journal: JAMA oncology
Published: September 23, 2021
Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 01, 2020
Blocking Coronavirus 19 Infection via the SARS-CoV-2 Spike Protein: Initial Steps.
Journal: ACS medicinal chemistry letters
Published: June 18, 2020
Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters using the Modified RAND/UCLA Delphi Process.
Journal: Cancers
Published: June 10, 2020
Unconventional Secondary Structure Mimics: Ladder-Rungs.
Journal: Angewandte Chemie (International ed. in English)
Published: February 19, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Journal: The Lancet. Oncology
Published: December 20, 2019
Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.
Journal: Nature medicine
Published: March 29, 2019
Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.
Journal: American journal of clinical oncology
Published: March 08, 2019
Last Updated: 09/26/2026